A group of leading African researchers trying to develop effective vaccines against HIV is trying to figure out how to ...

In 2005, a media furor briefly arose over a "killer" multidrug-resistant HIV strain isolated from a man in New York City (ACC Apr 13 2005). Virologists have continued to examine the virus and its ...

“It will also result in treatment resistance,” she said — strains of HIV that evolve to make medication ... or four days just takes it to a whole new level of cruelty and inhumanity and ...

Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir ...

An effective HIV-1 vaccine must therefore elicit antibodies that can neutralize many variants of the virus. While broadly neutralizing antibodies (bnAbs) have been isolated from HIV-1 infected ...

SAN FRANCISCO -- Most patients with HIV who received two broadly neutralizing antibodies (bNAbs) after pausing antiretroviral ...

After years of success reducing the number of new cases of AIDS, experts fear the change in government policy could mean this ...

In 2023, after a brief hiatus, tuberculosis regained from COVID its status as the world’s deadliest infectious disease—a ...

The 'broadly' refers to the ability of these types of antibodies to neutralise many strains of HIV ... of developing and testing these new approaches to HIV vaccine development.

The HIV Drugs Market is expected to grow steadily from 2025 to 2035, driven by advancements in antiretroviral therapy and increasing global awareness initiatives. Rising HIV prevalence, improved ...

“It will also result in treatment resistance,” she said — strains of HIV that evolve to make medication ineffective ... over the last three or four days just takes it to a whole new level of cruelty ...